Compare

MAIA Biotechnology, Inc. vs Cocrystal Pharma, Inc. vs FibroBiologics, Inc. vs Nanoviricides, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearMAIA Biotechnology, Inc.
MAIA
Cocrystal Pharma, Inc.
COCP
FibroBiologics, Inc.
FBLG
Nanoviricides, Inc.
NNVC
Year ended2025-12-312025-12-312025-12-312026-06-30
Revenuen/an/an/a$0
Revenue growth (YoY)n/an/an/an/a
Gross marginn/an/an/an/a
Operating marginn/an/an/an/a
Net marginn/an/an/an/a
Net income-$22.40M-$8.83M-$18.65M-$8.22M
EPS (Diluted)-$0.70-$0.78-$0.42-$0.41
Operating cash flow-$18.84M-$8.19M-$16.39M-$7.70M
Free cash flown/a-$8.20M-$16.66M-$7.78M
Cash & equivalents$0$7.03M$4.89M$2.79M
Total assets$9.70M$9.71M$9.62M$9.87M
Total liabilities$7.33M$3.38M$3.46M$1.20M
Shareholders' equity$2.38M$6.33M$6.16M$8.68M
Return on year-end equity-942.7%-139.5%-302.9%-94.7%
Shares outstanding38.62M13.78Mn/a23.01M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearMAIA Biotechnology, Inc.Cocrystal Pharma, Inc.FibroBiologics, Inc.Nanoviricides, Inc.
Latest$0
Ended 2024-12-31
$2.01M
Ended 2020-12-31
n/a$0
Ended 2026-06-30
1 year earlier$0
Ended 2023-12-31
$6.56M
Ended 2019-12-31
n/a$0
Ended 2025-06-30
2 years earlier$0
Ended 2022-12-31
n/an/a$0
Ended 2024-06-30
3 years earliern/an/an/a$0
Ended 2023-06-30
4 years earliern/an/an/an/a